MSCB-hDot1Lwt Citations (3)
Originally described in: hDOT1L links histone methylation to leukemogenesis.Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, Su L, Xu G, Zhang Y Cell. 2005 Apr 22;121(2):167-78. PubMed Journal
Articles Citing MSCB-hDot1Lwt
| Articles |
|---|
Mechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L.
Worden EJ, Hoffmann NA, Hicks CW, Wolberger C.
Cell. 2019 Feb 8. pii: S0092-8674(19)30151-5. doi: 10.1016/j.cell.2019.02.002.
PubMed
Associated Plasmids |
| Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Vatapalli R, Sagar V, Rodriguez Y, Zhao JC, Unno K, Pamarthy S, Lysy B, Anker J, Han H, Yoo YA, Truica M, Chalmers ZR, Giles F, Yu J, Chakravarti D, Carneiro B, Abdulkadir SA. Nat Commun. 2020 Aug 19;11(1):4153. doi: 10.1038/s41467-020-18013-7. PubMed |
| SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide. Du L, Liu W, Pichiorri F, Rosen ST. Cancer Gene Ther. 2022 Mar 25. pii: 10.1038/s41417-022-00450-9. doi: 10.1038/s41417-022-00450-9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.